Agenus Inc
Company Profile
Business description
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body’s immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).Agenus Inc along with its subsidiaries is a pharmaceutical company. It is engaged in discovery and development of revolutionary new treatments that engage the body's immune system to benefit patients suffering from cancer.
Contact
3 Forbes Road
Lexington MA 02421
USAT: +1 781 674-4400
E: investor@agenusbio.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2023
Employees
533
Stocks News & Analysis
stocks
7 charts on the AI stock boom one year after ChatGPT’s launch
stocks
Why Berkshire Hathaway’s success will continue after Charlie Munger ... and Warren Buffett
stocks
Morningstar initiates coverage on 3 new shares
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,285.10 | 12.60 | -0.17% |
| CAC 40 | 7,334.43 | 23.66 | 0.32% |
| DAX 40 | 16,325.62 | 110.19 | 0.68% |
| Dow JONES (US) | 35,950.89 | 520.47 | 1.47% |
| FTSE 100 | 7,499.77 | 46.02 | 0.62% |
| HKSE | 16,830.30 | 212.58 | -1.25% |
| NASDAQ | 14,226.22 | 32.27 | -0.23% |
| Nikkei 225 | 33,431.51 | 55.38 | -0.17% |
| NZX 50 Index | 11,367.51 | 37.31 | 0.33% |
| S&P 500 | 4,567.80 | 17.22 | 0.38% |
| S&P/ASX 200 | 7,073.20 | 14.10 | -0.20% |
| SSE Composite Index | 3,031.64 | 1.96 | 0.06% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Pilbara Minerals Ltd PLS | 3.61 | 0.03 | -0.82% |
| Mirvac Group MGR | 2.04 | 0.02 | -0.97% |
| South32 Ltd S32 | 3.09 | 0.01 | 0.32% |
| Santos Ltd STO | 6.90 | 0.01 | -0.14% |
| Telstra Group Ltd TLS | 3.79 | 0.03 | -0.79% |
| Origin Energy Ltd ORG | 8.18 | 0.06 | -0.73% |
| Scentre Group SCG | 2.67 | 0.02 | 0.75% |
| Woodside Energy Group Ltd WDS | 30.84 | 0.16 | -0.52% |
| Qantas Airways Ltd QAN | 5.35 | 0.05 | 0.94% |
| Endeavour Group Ltd EDV | 5.00 | 0.07 | 1.42% |